Bellamy N, Sothern RB, Campbell J: Rhythmic variations in pain perception in osteoarthritis of the knee. J Rheumatol. 1990, 17: 364-372.
CAS
PubMed
Google Scholar
Bellamy N, Sothern RB, Campbell J, Buchanan WW: Rhythmic variations in pain, stiffness and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002, 61: 1075-1080. 10.1136/ard.61.12.1075.
PubMed Central
CAS
PubMed
Google Scholar
Creamer P, Hunt M, Dieppe P: Pain mechanisms in osteoarthritis of the knee: Effect of intra-articular anaesthetic. J Rheumatol. 1996, 23: 1031-1036.
CAS
PubMed
Google Scholar
Crawford RW, Gie GA, Ling RS, Murray DW: Diagnostic value of intra-articular anaesthetic in primary osteoarthritis of the hip. J Bone Joint Surg Br. 1998, 80: 279-281. 10.1302/0301-620X.80B2.8299.
CAS
PubMed
Google Scholar
Kosek E, Ordeberg G: Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain. 2000, 88: 69-78. 10.1016/S0304-3959(00)00310-9.
CAS
PubMed
Google Scholar
Buffington ALH, Hanlon CA, McKeown MJ: Acute and persistent pain modulation of attention-related anterior cingulated fMRI activations. Pain. 2005, 113: 172-184. 10.1016/j.pain.2004.10.006.
PubMed
Google Scholar
Rowbotham MC, Kidd BL, Porreca F: Role of central sensitization in chronic pain: Osteoarthritis and rheumatoid arthritis compared to neuropathic pain. Proceedings of the 11th World Congress on Pain. August 21 – 26th 2005, Sydney, Australia. Edited by: Flor H, Kalso E, Dostrovsky J. 2006, Seattle; IASP Press
Google Scholar
Fraenkel M, Bogardus ST, Concato J, Wittink DR: Treatment options in knee OA. Arch Intern Med. 2004, 164: 1299-1304. 10.1001/archinte.164.12.1299.
PubMed
Google Scholar
Yaksh TL: Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 1997, 41: 94-111.
CAS
PubMed
Google Scholar
Hurley RW, Hammond DL: The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J Neurosci. 2000, 20: 1249-1259.
CAS
PubMed
Google Scholar
Sawynok J: Topical and peripherally acting analgesics. Pharmacol Rev. 2003, 55: 1-20. 10.1124/pr.55.1.1.
CAS
PubMed
Google Scholar
Likar R, Schafer M, Paulak F, Sittl R, Pipam W, Schalk H, Geissler D, Bernatzky G: Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg. 1997, 84: 1313-1317. 10.1097/00000539-199706000-00025.
CAS
PubMed
Google Scholar
Menendez L, Lastra A, Meana A, Hidalgo A, Baamonde A: Analgesic effects of loperamide in bone cancer pain in mice. Pharmacol Biochem Behav. 2005, 81: 114-121. 10.1016/j.pbb.2005.02.007.
CAS
PubMed
Google Scholar
Whiteside GT, Boulet JM, Walker K: The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid). J Pharmacol Exp Ther. 2005, 314: 1234-1240. 10.1124/jpet.105.088351.
CAS
PubMed
Google Scholar
Dray A: Alternatives to mu-opioid analgesics: delta-opioid and galanin-receptor selective compounds. Progress in Pain Research and Management. Edited by: Kalso E, McQuay HJ, Wiesenfeld-Hallin Z. 1999, Seattle: IASP Press, 269-280.
Google Scholar
Cahill CM, Morinville A, Lee M-C, Vincent J-P, Collier B, Beaudet A: Prolonged morphine treatment targets δ opioid receptors to neuronal plasma membranes and enhances δ-mediated antinociception. J Neurosci. 2001, 21: 7598-7607.
CAS
PubMed
Google Scholar
Koblish M, LaBuda CJ, Ajello CW, Gu M, Zhou QJ, Tuthill PA, Chu G, Le Bourdonnec B, Dolle RE, Little PJ: Anti-hyperalgesic activity of a novel delta-opioid receptor agonist. Soc Neurosci Abst. 2005, 490.14-
Google Scholar
Dray A: Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol. 1997, 75: 704-712. 10.1139/cjpp-75-6-704.
CAS
PubMed
Google Scholar
Dray A, Perkins MN: Bradykinin and inflammatory pain. Trends Neurosci. 1993, 16: 99-104. 10.1016/0166-2236(93)90133-7.
CAS
PubMed
Google Scholar
Wotherspoon G, Winter J: Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci Lett. 2000, 294: 175-178. 10.1016/S0304-3940(00)01561-5.
CAS
PubMed
Google Scholar
Shughrue PJ, Ky B, Austin CP: Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization study. J Comp Neurol. 2003, 465: 372-384. 10.1002/cne.10846.
CAS
PubMed
Google Scholar
Levy D, Zochodne DW: Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain. 2000, 86: 265-271. 10.1016/S0304-3959(00)00256-6.
CAS
PubMed
Google Scholar
Fox A, Wotherspoon G, McNair K, Hudson L, Patel S, Gentry C, Winter L: Regulation and function of spinal and peripheral neuronal B(1) bradykinin receptors in inflammatory mechanical hyperalgesia. Pain. 2003, 104: 683-691. 10.1016/S0304-3959(03)00141-6.
CAS
PubMed
Google Scholar
Ferreira J, Beirith A, Mori MAS, Araujo RC, Bader M, Pesqero JB, Calixto JB: Reduced nerve injury induced neuropathic pain in kinin B1 receptor knock-out mice. J Neurosci. 2005, 25: 2405-2412. 10.1523/JNEUROSCI.2466-04.2005.
CAS
PubMed
Google Scholar
Eisenbarth H, Rukwied R, Petersen M, Schmelz M: Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin. Pain. 2004, 110: 197-204. 10.1016/j.pain.2004.03.031.
CAS
PubMed
Google Scholar
Vellani V, Zachrisson O, McNaughton PA: Functional bradykinin B1 receptors are expressed in nociceptive neurons and are upregulated by the neurotrophin GDNF. J Physiol. 2004, 560: 391-401. 10.1113/jphysiol.2004.067462.
PubMed Central
CAS
PubMed
Google Scholar
Marceau F, Hess JF, Bachvarov DR: The B1 receptors for kinins. Pharmacol Rev. 1998, 50: 357-386.
CAS
PubMed
Google Scholar
Liang YF, Haake B, Reeh PW: Sustained sensitization and recruitment of rat cutaneous nociceptors by bradykinin and a novel theory of its excitatory action. J Physiol. 2001, 532: 229-239. 10.1111/j.1469-7793.2001.0229g.x.
PubMed Central
CAS
PubMed
Google Scholar
Fox A, Kaur S, Li B, Panasar M, Saha U, Davis C, Dragoni I, Colley S, Ritchie T, Bevan S, et al: Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor. Br J Pharmacol. 2005, 144: 889-899. 10.1038/sj.bjp.0706139.
PubMed Central
CAS
PubMed
Google Scholar
Stewart JM: Bradykinin antagonists: discovery and development. Peptides. 2004, 25: 527-732. 10.1016/j.peptides.2003.10.016.
CAS
PubMed
Google Scholar
Burgess GM, Perkins MN, Rang HP, Campbell EA, Browen MC, McIntyre P, Urban L, Dziadulewicz EK, Ritchie TJ, Hallet A, et al: Bradyzide, a potent nonpeptide B2 bradykinin receptors antagonist with long lasting oral activity in animal models of inflammatory hyperalgesia. Br J Pharmacol. 2000, 129: 77-86. 10.1038/sj.bjp.0703012.
PubMed Central
CAS
PubMed
Google Scholar
Gougat J, Ferrari B, Lionel S, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, et al: SSR240612 [(2R)-2-[((3R0-3-(1,3-benzodiol-5-yl)-3-{[(6-methoxy-2-napthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidyl]methyl}phenyl}-N-isoproyl-Nmethylpropana mide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther. 2004, 309: 661-669. 10.1124/jpet.103.059527.
CAS
PubMed
Google Scholar
Gabra BH, Sirois P: Beneficial effects of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-953, in attenuating streptozotocin-diabetic thermal hyperalgesia. Peptides. 2003, 24: 1131-1139. 10.1016/j.peptides.2003.06.003.
CAS
PubMed
Google Scholar
Flechtenmacher J, Talke M, Veith D, Heil K, Gebauer A, Schoenharting M: Icatibant induces pain relief in patients with osteoarthritis of the knee. Proceedings of the 9th World Congress of the OsteoArthritis Research Society Internation (OARSI). Chicago. 12: P332-December 2–5 2004
Fox A, Bevan S: Therapeutic potential of cannabinoid receptor agonists as analgesic agents. Expert Opin Investig Drugs. 2005, 14: 695-703. 10.1517/13543784.14.6.695.
CAS
PubMed
Google Scholar
Rice ASC, Farquhar-Smith WP, Nagy I: Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids. 2002, 66: 243-256. 10.1054/plef.2001.0362.
CAS
PubMed
Google Scholar
Mbvundula EC, Bunning RA, Rainsford KD: Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in vitro. J Pharm Pharmacol. 2006, 58: 351-358. 10.1211/jpp.58.3.0009.
CAS
PubMed
Google Scholar
Kreitzer Ac, Regeher WG: Retrograde signaling by endocannabinoids. Curr Opin Neurobiol. 2002, 12: 324-330. 10.1016/S0959-4388(02)00328-8.
CAS
PubMed
Google Scholar
de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, Rossi F, Maione S: Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience. 2005, 134: 269-281. 10.1016/j.neuroscience.2005.03.014.
CAS
PubMed
Google Scholar
Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC: Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA. 1999, 96: 12198-12203. 10.1073/pnas.96.21.12198.
PubMed Central
CAS
PubMed
Google Scholar
Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ: Are cannabinoids an effective and safe treatment option in the management of pain? A quantitative systematic review. BMJ. 2001, 323: 13-16. 10.1136/bmj.323.7303.13.
PubMed Central
CAS
PubMed
Google Scholar
Dyson A, Peacock M, Chen A, Courade J-P, Yaqoob , Groark A, Brain C, Loong Y, Fox A: Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat. Pain. 2005, 116: 129-137. 10.1016/j.pain.2005.03.037.
CAS
PubMed
Google Scholar
Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interactions with peripheral CB1 receptors. Pain. 1998, 75: 111-119. 10.1016/S0304-3959(97)00213-3.
CAS
PubMed
Google Scholar
Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U: Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003, 290: 1757-1762. 10.1001/jama.290.13.1757.
CAS
PubMed
Google Scholar
Malan TP, Ibrahim MM, Lai J, Vanderah TW, Makriyannis A, Porreca F: CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?. Curr Opin Pharmacol. 2003, 3: 62-67. 10.1016/S1471-4892(02)00004-8.
CAS
PubMed
Google Scholar
Labuda CJ, Koblish M, Little PJ: Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain. Eur J Pharmacol. 2005, 527: 172-175. 10.1016/j.ejphar.2005.10.020.
CAS
PubMed
Google Scholar
Valenzano KJ, Tafesse L, Lee G, Harrison JE, Bulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, et al: Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology. 2005, 48: 658-672. 10.1016/j.neuropharm.2004.12.008.
CAS
PubMed
Google Scholar
Elmes SJR, Winyard LA, Medhurst A, Clayton SJ, Wilson NM, Kendall AW, Chapman V: Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Pain. 2005, 118: 327-335. 10.1016/j.pain.2005.09.005.
CAS
PubMed
Google Scholar
Sokal DM, Elmes SJR, Kendall DA, Chapman V: Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurons via activation of Cb2 receptors in anaesthetized rats. Neuropharmacology. 2003, 45: 404-411. 10.1016/S0028-3908(03)00195-3.
CAS
PubMed
Google Scholar
Cravatt BF, Lichtman AH: The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol. 2004, 61: 149-160. 10.1002/neu.20080.
CAS
PubMed
Google Scholar
Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH: Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolyse. Proc Natl Acad Sci USA. 2001, 98: 9371-9376. 10.1073/pnas.161191698.
PubMed Central
CAS
PubMed
Google Scholar
Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, Cravatt BJ: Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther. 2004, 311: 441-448. 10.1124/jpet.104.069401.
CAS
PubMed
Google Scholar
Chang L, Luo L, Palmer JA, Sutton S, Wilson SJ, Barbier AJ, Breitenbucher JG, Chaplan SR, Webb M: Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol. 2006, 148: 102-113. 10.1038/sj.bjp.0706699.
PubMed Central
CAS
PubMed
Google Scholar
Cichewicz DL, McCarthy EA: Antinociceptive synergy between D9 tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther. 2003, 304: 1010-1015. 10.1124/jpet.102.045575.
CAS
PubMed
Google Scholar
England S, Bevan S, Dougherty RJ: PGE2 modulate the tetrodotoxin-resistant sodium current in neonatal dorsal root ganglion neurons via the cyclic AMP-protein kinase A cascade. J Physiol. 1996, 495: 429-440.
PubMed Central
CAS
PubMed
Google Scholar
Gold MS, Levine JD, Correa M: Modulation of TTX-R I Na by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci. 1998, 18: 10345-10355.
CAS
PubMed
Google Scholar
Bar K-J, Natura G, Telleria-Diaz A, Tascher P, Vogel R, Vasques E, Schaible H-G, Ebersberger A: Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E9EP1-EP4) receptors in spinal nociceptive processing of input from the normal and inflamed knee joint. J Neurosci. 2004, 24: 642-651. 10.1523/JNEUROSCI.0882-03.2004.
PubMed
Google Scholar
Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC: The acute hyperalgesic action of non-steroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci. 2001, 21: 5847-5853.
CAS
PubMed
Google Scholar
Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heidl C, Reinold H, Smart TG, Harvey K, Schultz B, Abo-Salem OM, et al: Gly α3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science. 2004, 304: 884-887. 10.1126/science.1094925.
CAS
PubMed
Google Scholar
Chandrasekharan NV, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, Simmons DL: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA. 2002, 99: 13926-13931. 10.1073/pnas.162468699.
PubMed Central
CAS
PubMed
Google Scholar
Mitchell JA, Warner TD: COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov. 2006, 5: 75-85. 10.1038/nrd1929.
CAS
PubMed
Google Scholar
Jakobsson PJ, Thoen S, Morgenstern R, Samuelsson B: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA. 1999, 96: 7220-7225. 10.1073/pnas.96.13.7220.
PubMed Central
CAS
PubMed
Google Scholar
Claveau D, Sirinyan M, Guay J, Gordon R, Chan C-C, Bureau Y, Riendeau D, Mancini JA: Microsomal prostaglandin synnthase-1 is a major terminal synthase that is selectively upregulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-arthritis model. J Immunol. 2003, 170: 4738-4744.
CAS
PubMed
Google Scholar
Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, et al: Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA. 2003, 100: 9044-9049. 10.1073/pnas.1332766100.
PubMed Central
CAS
PubMed
Google Scholar
Sommer C, Kress M: Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004, 361: 184-187. 10.1016/j.neulet.2003.12.007.
CAS
PubMed
Google Scholar
Ohtori S, Takahashi K, Moriya H, Myers RR: TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine. 2004, 29: 1082-1088. 10.1097/00007632-200405150-00006.
PubMed
Google Scholar
Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P, MacEwan DJ, Scott RH: TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurons. Neuropharmacology. 2002, 42: 93-106. 10.1016/S0028-3908(01)00163-0.
CAS
PubMed
Google Scholar
Schafers M, Marziniak M, Sorkin LS, Yaksh TL, Sommer C: Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol. 2004, 185: 160-168. 10.1016/j.expneurol.2003.09.015.
PubMed
Google Scholar
Schafers M, Sorkin LS, Geis C, Shubayev VI: Spinal ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia of rat. Neurosci Lett. 2003, 347: 179-182. 10.1016/S0304-3940(03)00695-5.
CAS
PubMed
Google Scholar
Grunke M, Schulze-Koops H: Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis. 2006, 65: 555-556. 10.1136/ard.2006.053272.
PubMed Central
CAS
PubMed
Google Scholar
Watkins LR, Maier S: Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002, 82: 981-1011.
CAS
PubMed
Google Scholar
Zhang N, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ: A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci USA. 2005, 102: 4536-4541. 10.1073/pnas.0406030102.
PubMed Central
CAS
PubMed
Google Scholar
Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ: Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001, 21: 5027-5035.
CAS
PubMed
Google Scholar
Weidler C, Holzer C, Harbuz M, Hofbauer R, Angele P, Scholmerich J, Straub RH: Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis. 2005, 64: 13-20. 10.1136/ard.2003.016154.
PubMed Central
CAS
PubMed
Google Scholar
Miller LE, Wiedler C, Falk W, Angele P, Schaumberger J, Scholmerich J, Straub R: Increased prevalence of semaphorin3C, a repellent of sympathetic nerve fibres in synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1156-1163. 10.1002/art.20110.
CAS
PubMed
Google Scholar
Niissalo S, Hukkanen M, Imai S, Tornwall J, Konttinen YT: Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci. 2002, 966: 384-399.
CAS
PubMed
Google Scholar
Zhang JM, LI H, Munir MA: Decreasing sympathetic sprouting in pathological sympathetic ganglia: a new mechanism for treating neuropathic pain using lidocaine. Pain. 2004, 109: 143-149. 10.1016/j.pain.2004.01.033.
CAS
PubMed
Google Scholar
Shinder V, Govrin-Lippmann R, Cohen S, Belenky M, Ilin P, Fried K, Wilkinson HA, Devor M: Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury. J Neurocytol. 1999, 28: 743-761. 10.1023/A:1007090105840.
CAS
PubMed
Google Scholar
Sato J, Perl ER: Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science. 1991, 251: 1608-1610. 10.1126/science.2011742.
CAS
PubMed
Google Scholar
Lee DH, Liu X, Kim HT, Chung K, Chung JM: Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats. J Neurophysiol. 1999, 81: 2226-2233.
CAS
PubMed
Google Scholar
Ali Z, Raja SN, Wesselmann U, Fuchs PN, Meyer RA, Campbell JN: Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain. 2000, 88: 161-168. 10.1016/S0304-3959(00)00327-4.
CAS
PubMed
Google Scholar
McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN: Excitatory amino acids, TNFα and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol. 2004, 137: 621-627. 10.1111/j.1365-2249.2004.02563.x.
PubMed Central
CAS
PubMed
Google Scholar
Neugebauer V: Glutamate receptor ligands. Handb Exp Pharmacol. 2007, 177: 217-249.
CAS
PubMed
Google Scholar
Szekely JI, Torok K, Mate G: The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites. Curr Pharm Des. 2002, 8: 887-912. 10.2174/1381612024607126.
CAS
PubMed
Google Scholar
Merle B, Itzstein C, Delmas PD, Chenu C: NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. J Cell Biochem. 2003, 90: 424-436. 10.1002/jcb.10625.
CAS
PubMed
Google Scholar
Salter DM, Wright MO, Millward-Sadler SJ: NMDA receptor expression and roles in human articular chondrocyte mechanotransduction. Biorheology. 2004, 41: 273-281.
CAS
PubMed
Google Scholar
Danysz W, Parsons CG: GlycineB recognition site of NMDA receptors and its antagonists. Amino Acids. 1998, 14: 205-206. 10.1007/BF01345263.
CAS
PubMed
Google Scholar
Quartaroli M, Fasdelli N, Bettelini L, Maraia G, Corsi M: GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice. Eur J Pharmacol. 2001, 430: 219-227. 10.1016/S0014-2999(01)01278-X.
CAS
PubMed
Google Scholar
Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, Rauck RL, Backonja MM, Quessy SN, Meisner PD: A randomized, double blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 2002, 59: 1694-1700.
CAS
PubMed
Google Scholar
Taniguchi K, Shinjo K, Mizutani M, Shimada K, Ishikawa T, Menniti F, Nagahisa A: Antinociceptive actions of CP-101,606, an NMDA receptor NR2B subunit antagonist. Br J Pharmacol. 1997, 122: 809-812. 10.1038/sj.bjp.0701445.
PubMed Central
CAS
PubMed
Google Scholar
Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, Winter J: Metabotropic glutamate receptor 5 up-regulation in A-fibers after spinal nerve injury: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci. 2002, 22: 2660-2668.
CAS
PubMed
Google Scholar
Dogrul A, Ossipov MH, Lai J, Malan TP, Porecca F: Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGluR5) antagonist, in experimental neuropathic pain in rats. Neurosci Lett. 2000, 292: 115-118. 10.1016/S0304-3940(00)01458-0.
CAS
PubMed
Google Scholar
Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM, Lynch JJ, Wade CL, Decker MW, Honore P: Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol. 2004, 506: 107-118. 10.1016/j.ejphar.2004.11.005.
CAS
PubMed
Google Scholar
Boxall SJ, Berthele A, Laurie DJ, Sommer B, Zieglgansberger W, Urban L, Tolle TR: Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation. Neuroscience. 1998, 82: 591-602. 10.1016/S0306-4522(97)00246-7.
CAS
PubMed
Google Scholar
Chiechio S, Caricasole A, Barletta E, Storto M, Catania MV, Copani A, Vertechy M, Nicolai R, Calvani M, Melchiorri D, Nicoletti F: L-Acetylcarnitine induces analgesia by selectively upregulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol. 2002, 61: 989-996. 10.1124/mol.61.5.989.
CAS
PubMed
Google Scholar
Vellani V, Mappleback S, Moriondo A, Davis JB, McNaughton PA: Protein kinase C activation gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol. 2001, 534: 813-825. 10.1111/j.1469-7793.2001.00813.x.
PubMed Central
CAS
PubMed
Google Scholar
Szallasi A, Blumberg PM: Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999, 51: 159-212.
CAS
PubMed
Google Scholar
Cantillon M, Vause E, Sykes D, Moon A, Hughes S: Safety, tolerability and efficacy of ALGRX 4975 in osteoarthritis (OA) of the knee. Journal of Pain. 2005, 6 (3): S39-
Google Scholar
Garcia-Martiez C, Humet M, Planells-Casas R, Gomis A, Capri M, Viaa F, de la Pena E, Sachez-Baez F, Carbonell T, de Felipe C, et al: Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci USA. 2002, 99: 2374-2379. 10.1073/pnas.022285899.
Google Scholar
Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, et al: AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther. 2005, 313: 474-484. 10.1124/jpet.104.079855.
CAS
PubMed
Google Scholar
Chizh B, Napolitano A, O'Donnell M, Wang J, Brooke A, Lai R, Aylott M, Bullman J, Gray E, Williams P, Appleby J: The TRPV1 antagonist SB705498 attenuates TRPV1 receptor mediated activity and inhibits inflammatory hyperalgesia in humans: Results from a Phase 1 study. Journal of Pain. 2006, 7 (4): S42-
Google Scholar
Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Pataapouian A: Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004, 41: 849-853. 10.1016/S0896-6273(04)00150-3.
CAS
PubMed
Google Scholar
Bland-Ward PA, Humphrey PP: P2x receptor mediated ATP-induced primary nociceptive neurone activation. J Auton Nerv Syst. 2000, 81: 146-151. 10.1016/S0165-1838(00)00122-3.
CAS
PubMed
Google Scholar
Honore P, Kage K, Mikusa J, Watt AT, Johnston JF, Wyatt JR, Faltynek CR, Jarvis MF, Lynch K: Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain. 2002, 99: 11-19. 10.1016/S0304-3959(02)00032-5.
CAS
PubMed
Google Scholar
Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, van Biesen T, Cartmell J, Bianchi B, et al: A-317491, a novel potent and selective non nucleotide antagonist of P2X(3) and P2X(2/3) receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA. 2002, 99: 17179-17184. 10.1073/pnas.252537299.
PubMed Central
CAS
PubMed
Google Scholar
Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003, 424: 778-783. 10.1038/nature01786.
CAS
PubMed
Google Scholar
Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TFC, Buckley NJ, Parson SH, Deuchars J: Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci. 2001, 21: 7143-7152.
CAS
PubMed
Google Scholar
Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, et al: Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain. 2005, 114: 386-396. 10.1016/j.pain.2005.01.002.
CAS
PubMed
Google Scholar
Chaplan SR, Guo H-Q, Lee DH, Luo L, Liu C, Kuei C, Velumian AAL, Butler MP, Brown SM, Dubin AE: Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J Neurosci. 2003, 23: 1169-1178.
CAS
PubMed
Google Scholar
Yao H, Donnelly DF, Ma C, LaMotte RH: Upregulation of the hyperpolarization activation cation current after chronic compression of the dorsal root ganglion. J Neurosci. 2003, 23: 2069-2074.
CAS
PubMed
Google Scholar
Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter KC, Harris AL, Koukourakis MI: Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2003, 5: R193-201. 10.1186/ar756.
PubMed Central
CAS
PubMed
Google Scholar
Leffler A, Monter B, Koltzenburg M: The role of the capsaicin receptor TRPV1 and acid sensing ion channels (ASICs) in proton sensitivity of subpopulation of primary nociceptive neurons in rats and mice. Neuroscience. 2006, 139: 699-709. 10.1016/j.neuroscience.2005.12.020.
CAS
PubMed
Google Scholar
Dube GR, Lehto SG, Breese NM, Baker SJ, Wang X, Matulenko MA, Honore P, Stewart AO, Moreland RB, Brioni JD: Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels. Pain. 2005, 117: 88-96. 10.1016/j.pain.2005.05.021.
CAS
PubMed
Google Scholar
Matzner O, Devor M: Hyperexcitability at sites of nerve injury depends on voltage sensitive sodium channels. J Neurophysiol. 1994, 72: 349-359.
CAS
PubMed
Google Scholar
Eglen RM, Hunter JC, Dray A: Ions in the fire: recent ion-channel research and approaches to pain therapy. Trends Pharmacol Sci. 1999, 8: 337-342. 10.1016/S0165-6147(99)01372-3.
Google Scholar
Devor M: Sodium channels and mechanisms of neuropathic pain. Pain. 2005, 7 (Suppl 1): S3-S12.
Google Scholar
Waxman SG, Dib-Hajj S: Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med. 2005, 11: 555-562. 10.1016/j.molmed.2005.10.004.
CAS
PubMed
Google Scholar
Gould HJ, England JD, Soignier RD, Nolan P, Minor LD, Liu ZP, Levinson SR, Paul D: Ibuprofen blocks changes in NaV1.7 and 1.8 sodium currents associated with complete Freunds adjuvant induced inflammation in rat. Pain. 2004, 5: 270-280. 10.1016/j.jpain.2004.04.005.
CAS
Google Scholar
Araujo MC, Sinnott CJ, Strichartz GR: Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions. Pain. 2003, 103: 21-29. 10.1016/S0304-3959(02)00350-0.
CAS
PubMed
Google Scholar
Kastrup J, Petersen P, Dejgard A, Angelo FR: Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy. Pain. 1987, 28: 69-75. 10.1016/0304-3959(87)91061-X.
CAS
PubMed
Google Scholar
Okuse K, Malik-Hall M, Baker MD, Poon W-YL, Chao MV, Wood JN: Annexin II light chain regulates sensory neurone-specific sodium channel expression. Nature. 2002, 417: 653-656. 10.1038/nature00781.
CAS
PubMed
Google Scholar
Rush AM, Craner MJ, Kageyama T, Dib-Haj SD, Waxman SG: Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons. Eur J Neurosci. 2005, 22: 39-49. 10.1111/j.1460-9568.2005.04186.x.
PubMed
Google Scholar
Yaksh TL: Calcium channels as therapeutic targets in neuropathic pain. J Pain. 2006, 7 (1 Suppl 1): S13-S30. 10.1016/j.jpain.2005.09.007.
CAS
PubMed
Google Scholar
Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, Chen L, Beedle AM, Ferguson SS, Mezghrani A, et al: ORL-1 receptor mediated internalization of N-type calcium channels. Nat Neurosci. 2005, 9: 31-40. 10.1038/nn1605.
PubMed
Google Scholar
Kim C, Jun K, Lee T, Kim SS, McEnery MW, Chin H, Kim HL, Park JM, Kim DK, Jung SJ, Kim J, Shin HS: Altered nociceptive response in mice deficient in the α(1B) subunit of the voltage-dependent calcium channel. Mol Cell Neurosci. 2001, 18: 235-245. 10.1006/mcne.2001.1013.
CAS
PubMed
Google Scholar
Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, Tanabe T: Suppression of inflammation and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. EMBO J. 2001, 20: 2349-2356. 10.1093/emboj/20.10.2349.
PubMed Central
CAS
PubMed
Google Scholar
Xiao WH, Bennett GJ: Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther. 1995, 274: 666-672.
CAS
PubMed
Google Scholar
Snutch TP: Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx. 2005, 2: 662-670. 10.1602/neurorx.2.4.662.
PubMed Central
PubMed
Google Scholar
Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J: Synaptic plasticity in spinal lamina 1 projection neurons that mediate hyperalgesia. Science. 2003, 299: 1237-1240. 10.1126/science.1080659.
CAS
PubMed
Google Scholar
Matthews EA, Dickenson AH: Effects of spinally delivered N-and P-type voltage dependent calacium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Eur J Pharmacol. 2001, 415: 141-149. 10.1016/S0014-2999(01)00812-3.
CAS
PubMed
Google Scholar
Flatters SJ, Bennett GJ: Ethosuximaide reverses paclitaxel and vincristine-induced painful peripheral neuropathy. Pain. 2004, 109: 150-161. 10.1016/j.pain.2004.01.029.
CAS
PubMed
Google Scholar
Lu Y, Westlund KN: Gabapentin attenuates nociceptive behaviours in an acute arthritis model in rats. J Pharmacol Exp Ther. 1999, 290: 214-219.
CAS
PubMed
Google Scholar
Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR: Injury type-specific calcium channel alpha (2) delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther. 2002, 303: 1199-1205. 10.1124/jpet.102.041574.
CAS
PubMed
Google Scholar
Jaffe M, Iacobellis D, Young JP, et al: Post-hoc results show beneficial effects of pre-gabalin in patients with osteoarthritis of the hip. Arthritis Rheum. 2000, 43 (Suppl): S337-
Google Scholar
Sah DWY, Ossipov MH, Porecca F: Neurotrophic factors as novel therapeutics for neuropathic pain. Nat Rev Drug Discov. 2003, 2: 460-472. 10.1038/nrd1107.
CAS
PubMed
Google Scholar
Zweifel LS, Kuruvilla R, Ginty DD: Functions and mechanisms of retrograde neurotrophin signaling. Nat Rev Neurosci. 2005, 6: 615-625. 10.1038/nrn1727.
CAS
PubMed
Google Scholar
Lu B, Pang PT, Woo NH: The Yin and Yang of neurotrophin action. Nat Rev Neurosci. 2005, 6: 603-614. 10.1038/nrn1726.
CAS
PubMed
Google Scholar
Ro LS, Chen ST, Tang LM, Jacobs JM: Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain. 1999, 79: 265-274. 10.1016/S0304-3959(98)00164-X.
CAS
PubMed
Google Scholar
Theodosiou M, Rush RA, Zhou XF, Hu D, Walker JS, Tracey DJ: Hyperalgesia due to nerve damage: role of nerve growth factor. Pain. 1999, 81: 245-255. 10.1016/S0304-3959(99)00018-4.
CAS
PubMed
Google Scholar
Hefti FF, Rosenthal A, Walicka PA, Wyatt S, Vergara G, Shelton DL, Davis AM: Novel class of pain drug based on antagonism of NGF. Trends Pharmacol Sci. 2005, 27: 85-91. 10.1016/j.tips.2005.12.001.
PubMed
Google Scholar
Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ: P38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002, 36: 57-68. 10.1016/S0896-6273(02)00908-X.
CAS
PubMed
Google Scholar
Fjell J, Cummings TR, Fried K, Black JA, Waxman SG: In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. J Neurophysiol. 1999, 81: 803-810.
CAS
PubMed
Google Scholar
Mamet J, Lazdunski M, Voilley N: How nerve growth factor drives physiological and inflammatory expression of acid-sensing ion channels 3 in sensory neurons. J Biol Chem. 2003, 278: 48907-48913. 10.1074/jbc.M309468200.
CAS
PubMed
Google Scholar
Petersen M, Segond von Banchet G, Heppelmann B, Koltzenburg M: Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience. 1998, 83: 161-168. 10.1016/S0306-4522(97)00374-6.
CAS
PubMed
Google Scholar
Ramer MS, Bradbury EJ, McMahon SB: Nerve growth factor induces P2X(3) expression in sensory neurons. J Neurochem. 2001, 77: 864-875. 10.1046/j.1471-4159.2001.00288.x.
CAS
PubMed
Google Scholar
Oddiah D, Anand P, McMahon SB, Rattray M: Rapid increase of NGF, BDNF and NT3 mRNAs in inflamed bladder. NeuroReport. 1998, 9: 1455-1458. 10.1097/00001756-199805110-00038.
CAS
PubMed
Google Scholar
Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL: Nerve growth factor and chronic prostatis/chronic pelvic pain syndrome. Urology. 2002, 59: 603-608. 10.1016/S0090-4295(01)01597-7.
PubMed
Google Scholar
Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R: Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992, 35: 351-355. 10.1002/art.1780350315.
CAS
PubMed
Google Scholar
Halliday DA, Zettler C, Rush RA, Scicchitano R, McNeil JD: Elevated growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res. 1998, 23: 919-922. 10.1023/A:1022475432077.
CAS
PubMed
Google Scholar
Sarchielli P, Alberti A, Floridi A, Gallai V: Levels of nerve growth factor in cerebrospinal fluid of chronic headache patients. Neurology. 2001, 57: 132-134.
CAS
PubMed
Google Scholar
Andreev N, Dimitrieva N, Kolzenburg M, McMahon SB: Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain. 1995, 63: 109-115. 10.1016/0304-3959(95)00024-M.
CAS
PubMed
Google Scholar
Apfel SC: Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?. Int Rev Neurobiol. 2002, 50: 393-413.
CAS
PubMed
Google Scholar
Sah DWY, Ossipov MH, Porecca F: Neurotrophic factors as novel therapeutics for neuropathic pain. Nat Rev Drug Discov. 2003, 2: 460-472. 10.1038/nrd1107.
CAS
PubMed
Google Scholar
Owolabi JB, Rizkalla G, Tehim A, Ross GM, Riopelle RJ, Kamboj R, Ossipov M, Bianm D, Wegert S, Porreca F, Lee DK: Characterization of antiallodynic actions ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther. 1999, 289: 1271-1276.
CAS
PubMed
Google Scholar
Colquhoun A, Lawrance GM, Shamovsky IL, Riopelle RJ, Ross GM: Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-benzoylamino)-4,9-dihydro-4methyl-8-oxo-pyrazolo-[5,1-b]-quinazoline-2-carboxylic acid] suggest altered NGF-p75NTR interactions in the presence of trkA. J Pharmacol Exp Ther. 2004, 310: 505-511. 10.1124/jpet.104.066225.
CAS
PubMed
Google Scholar
Lane N, Webster L, Shiaoping Lu, Gray M, Hefti F, Walicke P: RN624 (anti-NGF) improves pain and function in subjects with moderate knee osteoarthritis: a phase i study. Arthritis Rheum. 2005, 52 (Suppl): S461-10.1002/art.20791.
Google Scholar
Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005, 438: 1017-1021. 10.1038/nature04223.
CAS
PubMed
Google Scholar
Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB, Thompson SW: Brain derived neurotrophic factor modulates nociceptive sensory neurone input and NMDA-evoked responses in the rat spinal cord. J Neurosci. 1999, 19: 5138-5148.
CAS
PubMed
Google Scholar
Deng YS, Zhong JH, Zhou XF: Effects of endogenous neurotrophin on sympathetic sprouting in the dorsal root ganglia and allodynia following spinal nerve injury. Exp Neurol. 2000, 164: 344-350. 10.1006/exnr.2000.7432.
CAS
PubMed
Google Scholar
Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER, Lozano AM, Penn RD, Simpson RK, Stacy M, Wooten GF: ICV GDNF Study Group. Implanted intracerebroventricular. Glial cell line-derived neurotrophic factor. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 2003, 60: 69-73.
CAS
PubMed
Google Scholar
Welch MJ, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon. 2000, 38: 245-258. 10.1016/S0041-0101(99)00153-1.
CAS
PubMed
Google Scholar
Mense S: Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol. 2004, 251 (Suppl 1): I1-I7. 10.1007/s00415-004-1102-z.
PubMed
Google Scholar
Mahowald ML, Singh JA, Dykstra D: Long term effects of intra-articular botulinum toxin A for refractory joint pain. Neurotox Res. 2006, 9: 179-188.
CAS
PubMed
Google Scholar
Apostolidis A, Popat R, Yiangou Y, Cockyne D, Ford ABDW, Davis JB, Dasgupta P, Fowler CJ, Anand P: Decreased sensory receptors P2X (3) and TRPV1 in suburothelial nerve fibers following intradetrusor injection of botulinum toxin for human detrusor overactivity. J Urol. 2005, 174: 977-982. 10.1097/01.ju.0000169481.42259.54.
CAS
PubMed
Google Scholar
D'Amour FE, Smith DL: A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941, 72: 74-79.
Google Scholar
Woolfe G, MacDonald AD: The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944, 80: 300-307.
CAS
Google Scholar
Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev. 2001, 53: 597-652.
CAS
PubMed
Google Scholar
Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, Kazis L, Gale DR: The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med. 2001, 134: 541-549.
CAS
PubMed
Google Scholar
Hill CL, Gale DG, Chaisson CE, Skinner K, Kazis L, Gale ME, Felson DT: Knee effusions, popliteal cysts and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol. 2001, 28: 1330-1337.
CAS
PubMed
Google Scholar
Wluka AE, Wolfe R, Stuckey R, Cicuttini FM: How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis?. Ann Rheum Dis. 2004, 63: 264-268. 10.1136/ard/2003.007666.
PubMed Central
CAS
PubMed
Google Scholar
Van Der Kraan OM, Vitters EL, van de Putte LBA, van den Berg WB: Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol. 1989, 135: 1001-1014.
PubMed Central
CAS
PubMed
Google Scholar
Clarke KA, Heitmeyer SA, Smith AG, Taiwo YO: Gait analysis in a rat model of osteoarthritis. Physiol Behav. 1997, 62: 951-954. 10.1016/S0031-9384(97)00022-X.
CAS
PubMed
Google Scholar
Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ: Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterization. Pain. 2007
Google Scholar
Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS: Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003, 11: 821-830. 10.1016/S1063-4584(03)00163-8.
CAS
PubMed
Google Scholar
Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J: Pain releated behaviour in two model of osteoarthritis in the rat knee. Pain. 2004, 112: 83-93. 10.1016/j.pain.2004.08.004.
PubMed
Google Scholar
Pomonis JDM, Boulet JM, Gottshall SL, Phillips S, Rani S, Bunton T, Walker K: Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain. 2005, 114: 339-346. 10.1016/j.pain.2004.11.008.
CAS
PubMed
Google Scholar